It may be down, but today’s action has “Mad Money” host Jim Cramer questioning whether this sector is really out.» Read More
Which firms are racing to the forefront of this bold new science?
Attendance at the 4th Annual Stem Cell Summit is up, by about 50 percent, no less, over last year. All day long privately-held and publicly-traded companies are presenting to around 250 investors.
CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.
The Lightning Round is extended in this CNBC.com exclusive feature.
Cramer makes the call on viewers' favorite stocks.
The guys go behind the headlines and give you their take on the dismal economics numbers that capped off the worst January ever. But there are still places where you can make fast money.
Despite high hopes for President Barack Obama's stimulus package, Thursday's market action proved that investors should still be playing defense.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Investors can’t help but wonder what’s the best way to play Pharma after Pfizer said it would buy rival Wyeth for $60 billion, a 20% premium!
The Dow fell for the fourth day in a row as concerns about massive losses at Citigroup knocked its shares 17 percent lower, dragging down bank stocks...
Some call it the Super Bowl of healthcare. We’re talking about the JP Morgan Healthcare Conference kicking off Monday and it could move stocks.
In Tuesday's Fast Money Pops & Drops post we mistakenly reported that Celgene stock dropped after the firm reported revenues on the low-end of projections...
Following are the day’s biggest winners and losers. Find out why shares of Morgan Stanley and Dow Chemical popped while Reynolds American and Celgene dropped.
Merck, Lilly and Pfizer are all trading substantially higher. Will this bear market remedy keep working in the new year?
There’s no offense like a good defense. Find out how to keep your cash, even in the worst of times.
Here’s our Fast Money Final Trade. Our gang gives you Monday’s best trades, right now.
Following are the week’s biggest winners and losers. Find out why shares of Celgene and Goldman Sachs popped while Apple and Chevron dropped.
Is it possible that the Fed is trying to make cash so unattractive that you go out and take some risk?
The Dow fell on Wednesday as investors continued to digest whether the Fed had any more ammunition left after its bold move on Tuesday...
With gas cheaper, mortgage rates coming down and a winter of cheaper heating bills to possibly look forward to, there might be reason for some holiday cheer.